uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.
Show others and affiliations
2006 (English)In: Br J Haematol, ISSN 0007-1048, Vol. 133, no 4, 389-96 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2006. Vol. 133, no 4, 389-96 p.
Keyword [en]
Age Factors, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/therapeutic use, Dexamethasone/administration & dosage, Doxorubicin/administration & dosage, Epidemiologic Methods, Female, Humans, Male, Melphalan/administration & dosage, Middle Aged, Multiple Myeloma/*drug therapy, Peripheral Blood Stem Cell Transplantation, Prognosis, Treatment Outcome, Tumor Markers; Biological/blood, Vincristine/administration & dosage, beta 2-Microglobulin/blood
Identifiers
URN: urn:nbn:se:uu:diva-24957PubMedID: 16643445OAI: oai:DiVA.org:uu-24957DiVA: diva2:52731
Available from: 2007-02-08 Created: 2007-02-08 Last updated: 2011-01-11

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16643445&dopt=Citation
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 351 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf